mRNA Cancer Vaccine Shows Promise in Treating Aggressive Brain Tumours

A new mRNA cancer vaccine has shown promising results in reprogramming the immune system to attack tumours within 48 hours in a human clinical trial. The vaccine is personalized using the patient's own DNA and has the potential to improve treatment for aggressive brain tumours.